Nateglinide for type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2001年 / 43卷 / 1101期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
下载
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [1] Nateglinide therapy for type 2 diabetes mellitus
    Levien, TL
    Baker, DE
    Campbell, RK
    White, JR
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (11) : 1426 - 1434
  • [2] A review of nateglinide in the management of patients with type 2 diabetes
    Tentolouris, Nicholas
    Voulgari, Christina
    Katsilambros, Nicholas
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (06) : 797 - 807
  • [3] Pharmacodynamics and dose response of nateglinide in type 2 diabetes
    Hirschberg, Y
    McLeod, J
    Gareffa, S
    Spratt, D
    DIABETES, 1999, 48 : A100 - A100
  • [4] FDA approves nateglinide for treatment of type 2 diabetes
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (04) : 285 - +
  • [5] Nateglinide improves glycemic control in type 2 diabetes
    Iwasaki, K
    Okubo, M
    Ogawa, A
    Kawata, R
    Shimokawa, K
    Takasugi, K
    Tanabe, K
    Terazono, T
    Yamazaki, H
    DIABETES, 2001, 50 : A438 - A438
  • [6] Beneficial effects of nateglinide on insulin resistance in type 2 diabetes
    Hazama, Y
    Matsuhisa, M
    Ohtoshi, K
    Gorogawa, S
    Kato, K
    Kawamori, D
    Yoshiuchi, K
    Nakamura, Y
    Shiraiwa, T
    Kaneto, H
    Yamasaki, Y
    Hori, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (03) : 251 - 255
  • [7] Management of type 2 diabetes mellitus - Defining the role of nateglinide
    Carswell, CI
    Culy, CR
    Perry, CM
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2002, 10 (06) : 363 - 383
  • [8] Nateglinide versus repaglinide for type 2 diabetes mellitus in China
    Li, Chanjuan
    Xia, Jielai
    Zhang, Gaokui
    Wang, Suzhen
    Wang, Ling
    ACTA DIABETOLOGICA, 2009, 46 (04) : 325 - 333
  • [9] Nateglinide versus repaglinide for type 2 diabetes mellitus in China
    Chanjuan Li
    Jielai Xia
    Gaokui Zhang
    Suzhen Wang
    Ling Wang
    Acta Diabetologica, 2009, 46 : 325 - 333
  • [10] Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus
    Y. H. Walter
    D. I. Spratt
    S. Garreffa
    J. F. McLeod
    European Journal of Clinical Pharmacology, 2000, 56 : 129 - 133
12345